A phase 1 randomized, controlled trial tested the safety of a toothpaste that was specially formulated to be used as oral immunotherapy by adults with peanut allergy.
Going slow with everolimus reduces the risk of mouth ulcers and offers an alternative to steroid mouthwashes and their risk of oral fungal infections, say German researchers.